Articles

Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 CAR-T in advanced B-cell malignancies

Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; Cancer- and Immunometabolism Research Group, LMU Gene Center, Munich, Germany; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich
Department of Radiology, University Hospital, LMU Munich
Comprehensive Cancer Center Munich, LMU Munich, Munich
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; Cancer- and Immunometabolism Research Group, LMU Gene Center, Munich
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; Cancer- and Immunometabolism Research Group, LMU Gene Center, Munich
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich
Department of Medicine III, University Hospital, LMU Munich, Munich
Department of Radiology, University Hospital, LMU Munich
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany; Comprehensive Cancer Center Munich, LMU Munich, Munich
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; Cancer- and Immunometabolism Research Group, LMU Gene Center, Munich, Germany; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich
Haematologica Early view Feb 17, 2022 https://doi.org/10.3324/haematol.2021.280189